Aemetis (NASDAQ:AMTX) Raised to Sell at StockNews.com

Aemetis (NASDAQ:AMTX) was upgraded by stock analysts at StockNews.com to a “sell” rating in a note issued to investors on Friday.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $28.00 price target on shares of Aemetis in a report on Monday, December 23rd. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $12.95.

Aemetis Trading Up 4.8 %

Aemetis stock opened at $2.82 on Friday. The company has a market capitalization of $140.25 million, a PE ratio of -1.25 and a beta of 1.35. Aemetis has a 12 month low of $2.10 and a 12 month high of $7.03. The stock has a 50-day moving average price of $3.27 and a two-hundred day moving average price of $2.98.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The company had revenue of $81.44 million during the quarter, compared to analyst estimates of $77.79 million. During the same quarter in the previous year, the business posted ($0.59) earnings per share. As a group, analysts predict that Aemetis will post -2.02 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. FMR LLC increased its stake in Aemetis by 68.2% in the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after acquiring an additional 9,137 shares during the last quarter. Hutchinson Capital Management CA purchased a new position in shares of Aemetis during the second quarter valued at approximately $70,000. Barclays PLC lifted its stake in shares of Aemetis by 274.6% during the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after acquiring an additional 34,816 shares during the last quarter. Rhumbline Advisers boosted its stake in shares of Aemetis by 2,837.1% during the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock valued at $157,000 after purchasing an additional 50,528 shares during the period. Finally, Wellington Management Group LLP purchased a new stake in shares of Aemetis in the third quarter valued at approximately $177,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.